Skip to main content
NVDA-0.18%AAPL-0.21%GOOGL+0.59%MSFT-0.44%AMZN-0.15%TSM-1.68%SPCX+0.43%AVGO-0.97%META-0.47%TSLA-0.02%SKHY-5.20%MU-0.52%BRK-B+0.06%LLY-0.10%JPM-0.32%WMT-0.09%AMD-3.36%V-0.05%XOM+0.61%ASMLa-1.66%JNJ-0.27%INTC-5.57%MA-0.38%0700.HK-1.94%1398.HK+0.79%ABBV+1.62%BAC-0.18%ORCL-5.23%CVX-0.50%CSCO-1.82%COST-0.02%KO+0.32%LRCX-5.65%CAT-1.29%AP2d-1.55%0005.HK-0.78%AMAT-3.17%HSBA.L-1.30%UNH-1.22%PG+0.25%DELL-5.35%GE-0.39%MS-1.22%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.03%HD-1.53%0939.HK+1.66%GS-0.88%NZDJPY-2.37%AUDJPY-1.75%CHFJPY-1.55%EURNZD+1.26%NZDUSD-1.24%NZDCAD-1.23%GBPNZD+1.20%GBPJPY-1.18%USDJPY-1.17%EURJPY-1.16%CADJPY-1.16%NZDCHF-0.86%USDTHB+0.75%AUDNZD+0.65%AUDCAD-0.62%EURAUD+0.60%AUDUSD-0.59%GBPAUD+0.55%GBPTRY+0.41%USDCHF+0.40%EURCHF+0.38%CADCHF+0.37%GBPCHF+0.35%USDTRY+0.33%GBPHKD+0.32%GBPMXN-0.28%AUDCHF-0.20%NZDSGD+0.20%USDILS+0.16%NZDMXN+0.14%USDCNH+0.09%USDZAR-0.08%GBPZAR-0.06%USDMXN-0.05%EURZAR-0.05%AUDNOK+0.05%AUDSGD+0.05%GBPCAD-0.04%EURGBP+0.04%USDCOP-0.04%USDPLN-0.04%CHFSEK+0.03%USDDKK-0.03%CHFSGD+0.03%CHFNOK+0.03%AUDDKK+0.03%GBPUSD-0.02%PLNJPY+0.02%EURCZK-0.02%EURPLN-0.02%EURSEK+0.02%EURNOK+0.02%EURHKD+0.02%USDNOK-0.01%EURSGD+0.01%USDSEK-0.01%NOKJPY-0.01%SGDJPY-0.01%USDHKD+0.01%USDSGD-0.01%EURCNH+0.01%EURDKK-0.01%GBPSGD+0.01%EURUSD-0.01%EURCAD0.00%USDCAD0.00%USOIL-1.00%UKOIL-0.88%W1-0.61%C1-0.38%GAGUSD-0.12%XAGUSD-0.12%XPTUSD+0.08%S1-0.08%GAUUSD+0.07%XAUUSD+0.07%XNGUSD+0.05%HG1+0.02%BTCUSD-1.87%ETHUSD-0.74%USDTUSD-0.02%XRPUSD-3.74%SOLUSD-2.41%TRXUSDT+0.42%ZECUSDT-12.57%DOGEUSD-3.09%XMRUSDT-0.55%LINKUSD-2.48%XLMUSD-2.93%BCHUSDT-10.27%LTCUSD-1.54%UNIUSD-2.32%TONUSD+24.88%HBARUSDT-2.44%SUIUSD-5.02%TAOUSDT-7.27%AAVEUSD-3.74%DOTUSDT-1.47%ICPUSDT+1.51%ONDOUSDT-4.06%WLDUSDT-3.87%ATOMUSDT-2.00%ARBUSDT-5.60%JUPUSDT-2.53%INJUSDT-2.89%STXUSDT-7.45%FETUSDT-3.39%TIAUSDT-2.18%PYTHUSDT-1.66%SEIUSDT-6.02%IMXUSDT-5.44%WIFUSDT-6.36%GRTUSDT-5.39%OPUSDT-5.01%POLUSDT-5.63%IOTAUSDT-5.08%AXSUSDT-3.01%FARTCOINUSDT-3.69%EOSUSDT-3.65%DYDXUSDT-2.22%ORDIUSDT-0.75%GALAUSDT-5.34%NOTUSDT-2.97%RONINUSDT-4.56%NVDA-0.18%AAPL-0.21%GOOGL+0.59%MSFT-0.44%AMZN-0.15%TSM-1.68%SPCX+0.43%AVGO-0.97%META-0.47%TSLA-0.02%SKHY-5.20%MU-0.52%BRK-B+0.06%LLY-0.10%JPM-0.32%WMT-0.09%AMD-3.36%V-0.05%XOM+0.61%ASMLa-1.66%JNJ-0.27%INTC-5.57%MA-0.38%0700.HK-1.94%1398.HK+0.79%ABBV+1.62%BAC-0.18%ORCL-5.23%CVX-0.50%CSCO-1.82%COST-0.02%KO+0.32%LRCX-5.65%CAT-1.29%AP2d-1.55%0005.HK-0.78%AMAT-3.17%HSBA.L-1.30%UNH-1.22%PG+0.25%DELL-5.35%GE-0.39%MS-1.22%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.03%HD-1.53%0939.HK+1.66%GS-0.88%NZDJPY-2.37%AUDJPY-1.75%CHFJPY-1.55%EURNZD+1.26%NZDUSD-1.24%NZDCAD-1.23%GBPNZD+1.20%GBPJPY-1.18%USDJPY-1.17%EURJPY-1.16%CADJPY-1.16%NZDCHF-0.86%USDTHB+0.75%AUDNZD+0.65%AUDCAD-0.62%EURAUD+0.60%AUDUSD-0.59%GBPAUD+0.55%GBPTRY+0.41%USDCHF+0.40%EURCHF+0.38%CADCHF+0.37%GBPCHF+0.35%USDTRY+0.33%GBPHKD+0.32%GBPMXN-0.28%AUDCHF-0.20%NZDSGD+0.20%USDILS+0.16%NZDMXN+0.14%USDCNH+0.09%USDZAR-0.08%GBPZAR-0.06%USDMXN-0.05%EURZAR-0.05%AUDNOK+0.05%AUDSGD+0.05%GBPCAD-0.04%EURGBP+0.04%USDCOP-0.04%USDPLN-0.04%CHFSEK+0.03%USDDKK-0.03%CHFSGD+0.03%CHFNOK+0.03%AUDDKK+0.03%GBPUSD-0.02%PLNJPY+0.02%EURCZK-0.02%EURPLN-0.02%EURSEK+0.02%EURNOK+0.02%EURHKD+0.02%USDNOK-0.01%EURSGD+0.01%USDSEK-0.01%NOKJPY-0.01%SGDJPY-0.01%USDHKD+0.01%USDSGD-0.01%EURCNH+0.01%EURDKK-0.01%GBPSGD+0.01%EURUSD-0.01%EURCAD0.00%USDCAD0.00%USOIL-1.00%UKOIL-0.88%W1-0.61%C1-0.38%GAGUSD-0.12%XAGUSD-0.12%XPTUSD+0.08%S1-0.08%GAUUSD+0.07%XAUUSD+0.07%XNGUSD+0.05%HG1+0.02%BTCUSD-1.87%ETHUSD-0.74%USDTUSD-0.02%XRPUSD-3.74%SOLUSD-2.41%TRXUSDT+0.42%ZECUSDT-12.57%DOGEUSD-3.09%XMRUSDT-0.55%LINKUSD-2.48%XLMUSD-2.93%BCHUSDT-10.27%LTCUSD-1.54%UNIUSD-2.32%TONUSD+24.88%HBARUSDT-2.44%SUIUSD-5.02%TAOUSDT-7.27%AAVEUSD-3.74%DOTUSDT-1.47%ICPUSDT+1.51%ONDOUSDT-4.06%WLDUSDT-3.87%ATOMUSDT-2.00%ARBUSDT-5.60%JUPUSDT-2.53%INJUSDT-2.89%STXUSDT-7.45%FETUSDT-3.39%TIAUSDT-2.18%PYTHUSDT-1.66%SEIUSDT-6.02%IMXUSDT-5.44%WIFUSDT-6.36%GRTUSDT-5.39%OPUSDT-5.01%POLUSDT-5.63%IOTAUSDT-5.08%AXSUSDT-3.01%FARTCOINUSDT-3.69%EOSUSDT-3.65%DYDXUSDT-2.22%ORDIUSDT-0.75%GALAUSDT-5.34%NOTUSDT-2.97%RONINUSDT-4.56%
O&

Organon & Co. (OGN)

NYSE • Healthcare

$13.63
-$0.03 (-0.3%)
Market closed

Last close at September 10, 2026 at 20:00 UTC

Open$13.66
Day Range$13.63 - $13.66
Avg. Volume (3M)3.2M
Market Cap$3.5B
P/E Ratio17.3
52 Week Range
$5.69$13.79
Next EarningsIn 59 daysNov 9, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$1.5B100%
Gross Profitminus cost of goods$847M54%
Operating Incomeminus R&D and overhead$323M21%
Net Incomeminus taxes and the rest$108M7%

In plain terms: out of every $100 in revenue, Organon & Co. keeps $7 as net profit.

Fundamentals & Financials

Revenue (TTM)
$6.1B
Net Income (TTM)
$209M
EPS (TTM)
$0.79
ROA (TTM)
1.59%
Current Ratio
1.95
Dividend Yield
0.17%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-13.7%Q1 2026$0.63
-14.5%Q2 2026$0.71
0.0%Q3 2026$0.85
Next

Nov 9

in 59 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Met

Organon & Co. missed consensus on adjusted EPS in the second fiscal quarter of 2026, posting $0.85 versus the $0.90 estimate, roughly -5.7%, and the results were reported on July 31, 2026. Adjusted EPS was down 15% from $1.00 a year ago, operating cash flow was negative about $224.7 million, and the company paid $5.0 million in dividends.

View full earnings history

About Organon & Co.

Organon & Co. develops and markets prescription medicines in healthcare, with a portfolio centered on women's health, biosimilars, and established therapies; it trades on the NYSE under OGN and recorded $6.2 billion in revenue in FY2025. The company operates as a drug manufacturer with products used across reproductive care, chronic disease, and allergy treatment.

Name
Organon & Co.
CEO
Joseph T. Morrissey Jr.
Website
www.organon.com
Industry
Healthcare
Year Founded
2020
Employees
10,000

Today's Snapshot

AI-generated

OGN ended the day slightly lower at 13.63, while its sector was weaker. Shares changed hands at about two-thirds of its usual level.

Trading Volume

Below 10d avg (3.5M)

2M

vs S&P 500 Today

Moderate Outperformance

+0.28%

Updated: September 10, 2026 at 20:33 UTC

Technical Indicators

3 Buy3 Neutral2 Sell
OGN presents a split technical picture that favors the buy classification on longer horizons while showing short-term weakness: the ADX is high, indicating a strong trend, yet momentum indicators are sharply negative and CCI is deeply oversold. The share price sits near short-term averages but remains comfortably above the 200-day level, and narrow Bollinger bands indicate low volatility even as OBV points to recent selling pressure. Classic pivots are essentially neutral, leaving price action to reflect mixed forces. Technical takeaway: Buy — longer-term moving averages remain supportive despite pronounced short-term selling and low volatility.
All signals
  • EMA (5 indicators)$11.00 - $13.72
    Buy
  • RSI (14)39.36
    Neutral
  • Stochastic %K (14, 3, 3)26.67
    Neutral
  • MACD Level (12, 26)0.03
    Neutral

Peers & Related Assets

GRDNGuardian Pharmacy Services, Inc.
$43.83+1.0%
HRMYHarmony Biosciences Holdings, Inc.
$41.1-1.3%
MDPediatrix Medical Group, Inc.
$26.73-1.3%
NUVBNuvation Bio Inc.
$6.28-3.7%
AUPHAurinia Pharmaceuticals Inc.
$16.11-0.9%
PAHCPhibro Animal Health Corporation
$36.58-0.6%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.